Encompass Health Corp/ US29261A1007 /
31/10/2024 20:58:25 | Chg. -1.63 | Volume | Bid21:25:00 | Ask21:25:00 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
99.73USD | -1.61% | 19,521 Turnover: 1.04 mill. |
-Bid Size: - | -Ask Size: - | 10.01 bill.USD | 0.60% | 28.34 |
Assets
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 910.5000 | 1,019.7000 | 1,310.1000 | 1,391.8000 | 1,517.1000 | ||||||
Intangible Assets | 88.2000 | 306.1000 | 419.4000 | 411.3000 | 403.1000 | ||||||
Long-Term Investments | 0.0000 | - | - | - | - | ||||||
Fixed Assets | - | - | - | - | 4,191.5000 | ||||||
Inventories | - | - | - | - | - | ||||||
Accounts Receivable | 261.8000 | 323.2000 | 410.5000 | 443.8000 | 472.1000 | ||||||
Cash and Cash Equivalents | 64.5000 | 66.7000 | 61.6000 | 40.5000 | 54.4000 | ||||||
Current Assets | 580.4000 | 686.6000 | 598.7000 | 654.5000 | 702.2000 | ||||||
Total Assets | 2,534.4000 | 3,408.8000 | 4,606.1000 | 4,681.9000 | 4,893.7000 |
Liabilities
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 61.9000 | 53.4000 | 61.6000 | 68.3000 | 78.4000 | ||||||
Long-term debt | 1,505.2000 | 2,110.8000 | 3,134.7000 | 2,979.3000 | 2,545.4000 | ||||||
Liabilities to Banks | 1,505.2000 | 2,110.8000 | 3,134.7000 | 2,979.3000 | 2,545.4000 | ||||||
Provisions | - | - | - | - | - | ||||||
Liabilities | 1,959 | 2,789.3000 | 3,826.8000 | 3,753.2000 | 3,469.1000 | ||||||
Share Capital | - | 1 | 1.1000 | 1.1000 | 1.1000 | ||||||
Total Equity | 344.6000 | 619.5000 | 779.3000 | 928.7000 | 1,424.6000 | ||||||
Minority Interests | 137.6000 | 146.3000 | 167.9000 | 192.8000 | 242.9000 | ||||||
Total liabilities equity | 2,534.4000 | 3,408.8000 | 4,606.1000 | 4,681.9000 | 4,893.7000 |
Income Statement
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2,273.2000 | 2,374.3000 | 3,115.7000 | 3,707.2000 | 3,971.4000 | ||||||
Depreciation (total) | 94.7000 | 107.7000 | 139.7000 | 172.6000 | 183.8000 | ||||||
Operating Result | 482.3000 | - | - | - | - | ||||||
Interest Income | -100.4000 | 109.2000 | 142.9000 | 172.1000 | 154.4000 | ||||||
Income Before Taxes | 384 | 386.9000 | 395.6000 | 482 | 496.4000 | ||||||
Income Taxes | 12.7000 | 110.7000 | 141.9000 | 163.9000 | 160.6000 | ||||||
Minority Interests Profit | -57.8000 | -59.7000 | -69.7000 | -70.5000 | -79.1000 | ||||||
Net Income | 323.6000 | 215.7000 | 181.5000 | 247.6000 | 256.3000 |
Per Share
Cash Flow
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 470.3000 | 444.9000 | 484.8000 | 605.5000 | 657.2000 | ||||||
Cash Flow from Investing Activities | -226.2000 | -876.9000 | -1,129.8000 | -245 | -284.5000 | ||||||
Cash Flow from Financing | -312.4000 | 434.2000 | 639.9000 | -381.6000 | -358.8000 | ||||||
Decrease / Increase in Cash | -68.3000 | 2.2000 | -5.1000 | -21.1000 | 13.9000 | ||||||
Employees | 23,600 | 29,000 | 34,700 | 35,710 | 29,370 |